Evaluation of 8 mg Intravitreal Aflibercept Injection for Neovascular Age-Related Macular Degeneration: Results from the Phase 2 CANDELA Study

  • W. Lloyd Clark, MD, FASRS
  • Video
  • Published 2022

See more